Hage, Camille
Gan, Hoong-Wei
Ibba, Anastasia http://orcid.org/0000-0002-6899-3884
Patti, Giuseppa
Dattani, Mehul http://orcid.org/0000-0002-0365-5809
Loche, Sandro
Maghnie, Mohamad http://orcid.org/0000-0002-7183-5238
Salvatori, Roberto http://orcid.org/0000-0001-6495-2244
Article History
Accepted: 6 July 2021
First Online: 20 August 2021
Competing interests
: R.S. has served on advisory boards for Novo Nordisk and Ipsen. M.D. has served on advisory boards for Novo Nordisk, Pfizer and Ipsen and has received consulting/lecture fees from Sandoz, Pfizer and Novo Nordisk. M.M. has served on advisory boards for Ascendis, Biomarin, Merck, Novo Nordisk, Pfizer and Merk and has received lecture fees at several meetings. S.L. has received lecture fees and served on advisory board for Merck Serono, Ipsen and Sandoz. The other authors declare no competing interests.